T80.310A ABO incompatibility with acute hemolytic transfusion reaction, initial encounter

Name of the Condition

• ABO incompatibility with acute hemolytic transfusion reaction, initial encounter.

Summary

This condition describes an adverse immune reaction that occurs when blood or blood products with incompatible ABO antigens are transfused, leading to acute hemolysis. It is a serious complication that can cause systemic effects, including organ damage. The reaction is driven by pre-existing antibodies in the recipient that target antigens on the transfused red blood cells, and "initial encounter" indicates the first episode of care for this reaction.

Causes

ABO incompatibility reactions result from the transfusion of blood or blood products containing ABO antigens that do not match the recipient's blood type. This mismatch triggers an immune response, where the recipient's antibodies bind to the donor red blood cells, leading to their destruction (hemolysis). The reaction can occur with red blood cells, plasma, or platelets if ABO compatibility is not maintained.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or abdominal pain

Diagnosis

Diagnosis involves clinical assessment of symptoms, laboratory tests to detect hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and confirmation of ABO incompatibility through blood typing and crossmatching. Additional tests may include direct antiglobulin testing (Coombs test) to identify antibody-mediated destruction of red blood cells.

Treatment Options

Treatment focuses on stopping the transfusion immediately, managing hemolysis (e.g., fluid support, diuretics), and addressing complications such as hypotension or renal impairment. Supportive care, including monitoring for organ dysfunction, is critical. In severe cases, additional interventions like dialysis may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Most patients recover with appropriate care, but severe cases can lead to organ damage or death. Follow-up includes monitoring for delayed complications, such as renal failure, and ensuring future transfusions are ABO-compatible.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multi-organ dysfunction
• Death (in severe cases)

Lifestyle & Prevention

Prevention relies on strict adherence to blood typing, crossmatching, and verification protocols before transfusion. Patients with a history of transfusion reactions should have their blood type and antibody status documented clearly. Avoiding unnecessary transfusions and using leukoreduced products may reduce risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms of a transfusion reaction occur, such as fever, chills, pain, or dark urine, during or after a blood transfusion. Prompt evaluation is essential to minimize complications.

Tips for Medical Coders

Document the acute hemolytic nature of the reaction and confirm the initial encounter status. Ensure ABO incompatibility is clearly linked to the transfusion event, with supporting clinical details (e.g., symptoms, lab results) to justify the code.